The inclusion of IgG/IgM aPS/PT in diagnostic assessments may improve the overall performance for diagnosing APS, particularly in situations where conventional aPL tests consistently yield negative results. The gene discussed is CD40LG; the disease is autoimmune polyendocrinopathy.